2016
DOI: 10.1016/j.jaci.2015.12.512
|View full text |Cite
|
Sign up to set email alerts
|

Granulomatous and Lymphocytic Interstitial Lung Disease (GLILD) Associated with KMT2D Gene Mutation in Kabuki Syndrome

Abstract: RATIONALE: Granulomatous and lymphocytic interstitial lung disease (GLILD) is a known complication of CVID. Humoral immunodeficiency associated with Kabuki syndrome is increasingly recognized. Here we present a patient with Kabuki syndrome, due to a mutation in lysine (K)specific methyltransferase 2D (KMT2D), complicated by GLILD. METHODS: Chart review of flow cytometry results, clinical lab results, and lung pathology are presented. RESULTS: A 13-year-old male with Kabuki syndrome presented with recurrent oti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…In selected cases, particularly, but not restricted to, pediatric presentations, genetic testing may be warranted. For example, patients with mutations in CTLA4, LRBA, TACI, KMT2D, XIAP, RAG1, and NFKB1 have been found within so called "CVID" cohorts, and ILD is a common feature of other monogenic PIDs (34,39,(51)(52)(53)(54)(55)(56)(57). A molecular diagnosis enables other therapeutic approaches such as CTLA-4 fusion proteins abatacept and belatacept for the inflammatory associations of CTLA-4 and LRBA deficiency (58,59).…”
Section: Investigations For Cvid-related Ildmentioning
confidence: 99%
“…In selected cases, particularly, but not restricted to, pediatric presentations, genetic testing may be warranted. For example, patients with mutations in CTLA4, LRBA, TACI, KMT2D, XIAP, RAG1, and NFKB1 have been found within so called "CVID" cohorts, and ILD is a common feature of other monogenic PIDs (34,39,(51)(52)(53)(54)(55)(56)(57). A molecular diagnosis enables other therapeutic approaches such as CTLA-4 fusion proteins abatacept and belatacept for the inflammatory associations of CTLA-4 and LRBA deficiency (58,59).…”
Section: Investigations For Cvid-related Ildmentioning
confidence: 99%